STAT3 and central nervous system cancer: Silencing KAT6B inhibits the enrichment of RNA polymerase II (RNA pol II) and histone H3 lysine 23 acetylation (H3K23ac) on the STAT3 promoter, while loss of STAT3 reverses KAT6B-induced inhibition of ferroptosis in glioma cells.